3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 4
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
507
OTHER
424
NIH
99
NETWORK
30
OTHER_GOV
5
FED
2
UNKNOWN
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Dermatologic
3
Thoracic
2
Other solid neoplasm
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
UNKNOWN
×
Gynecologic
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled